Evaluation of a rotational-asymmetric multifocal intraocular lens with a standard toricity and a +1.5 D near addition

Session Details

Session Title: Cataract
Session Date/Time: Saturday 11/02/2017 | 08:30-11:00
Paper Time: 09:18
Venue: Auditorium 1

First Author: F. Kretz GERMANY
Co Author(s): H. Kaymak  R. Gerl  M. Mueller  G. Auffarth  M. Gerl  D. Breyer  

Abstract Details

Purpose:

Clinical evaluation of a rotational-asymmetric multifocal intraocular lens with a standard toricity and a +1.5 D near addition for the correction of presbyopia and astigmatism during cataract surgery.

Setting:

Augenklinik Ahaus, Germany; International Vision Correction Research Centre Network (IVCRC.net), University of Heidelberg, Germany

Methods:

In a prospective multicenter study patients patients that underwent cataract surgery with a corneal astigmatism ? 0.75 D receives a rotational-asymmetric multifocal intraocular lens with a standard toricity and a +1.5 D near addition (LS-313MF15 T1-T6, Oculentis, Germany). The preoperative biometry was performed with the IOL-Master 700 (Carl Zeiss Meditech, Germany). Subjective refraction, corrected and uncorrected visual acuity, monocular and binocular [decimal] for distance, intermediate and near as well as binocular defocus curve analysis and rotational stability were evaluated.

Results:

A significant reduction of astigmatism from -1.36 D to -0,25 D could be found. The mean postoperative monocular UDVA was 1.06, the UIVA was 1.02 and the UNVA was 0.51, respectively. Mean IOL rotation was 1.6ﾰ.

Conclusions:

Rotational-asymmetric multifocal intraocular lenses with a standard toricity and a +1.5 D near addition based on a plate haptic design show an excellent rotational stability and sufficient astigmatism correction even for small grades of astigmatism. The evaluated +1.5 D near addition MIOL shows his benefits for distance and intermediate visual acuity while still offering acceptable near visual acuity.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a competing company